Advertisement

Induction of Brain Hypothermia Treatment

  • Nariyuki Hayashi
  • Dalton W. Dietrich

Abstract

Mild brain hypothermia treatment (34°C) is indicated in patients with a Glasgow Coma Scalescore (GCS) of 8 or less, serum glucose concentration less than 230 mg/dl, and no clinical signs of herniation. The duration is variable at 3–7 days, and brain hypothermia should be started within 3h after insult (Fig. 28, Chap. 23). Moderate brain hypothermia (32°–33°C) is indicated in patients with a GCS of 6 or less, and serum glucose concentration less than 180 mg/dl. The duration is variable at 4–14 days. Early brain hypothermia treatment is indicated for the prevention of vegetation. A flat electroencephalogram (EEG) and no response of the auditory brain stem evoked potential (ABER), breathing arrest, and pupil dilatation are not signs of contraindication at admission (Fig. 79). This is because, despite the disappearance of cell membrane potentials shortly after brain damage, many neuronal cells remain alive. However, these critical signs suggest the contraindication of brain hypothermia treatment 3–6 h after brain trauma and stroke.

Keywords

Serum Glucose Brain Edema Disseminate Intravascular Coagulation Cerebral Perfusion Pressure Vasopressin Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Corte FD, Mancini A, Valle D, Gallizzi F, Carducci P, Mignani V, De Marinis L (1998) Provocative hypothalamopituitary axis tests in severe head injury: correlation with severity and prognosis. Crit Care Med 26:1419–1426PubMedCrossRefGoogle Scholar
  2. 2.
    Hayashi N (1995) Cerebral hypothermia treatment. In: Hayashi N (ed) Cerebral hypothermia treatment. Sogo Igaku, Tokyo, pp 1–105Google Scholar
  3. 3.
    Hayashi N (1997) Prevention of vegetation after severe head trauma and stroke by combination therapy of cerebral hypothermia and activation of immunedopaminergic nervous system. Proceedings of the 6th annual meeting of Society for Treatment of Coma 6:133–145Google Scholar
  4. 4.
    Hayashi N (2000) Enhanced neuronal damage in severely brain injured patients by hypothalamus, pituitary, and adrenal axis neuro-hormonal changes. In: Hayashi N (ed) Brain hypothermia. Springer, Berlin Heidelberg New York Tokyo, pp 3–26CrossRefGoogle Scholar
  5. 5.
    Hayashi N (2000) The clinical issue and effectiveness of brain hypothermia treatment for severe brain injured patients. In Hayashi N (ed) Brain hypothermia. Springer, Berlin Heidelberg New York Tokyo, pp 121–151CrossRefGoogle Scholar
  6. 6.
    Hayashi N, Hirayama T, Utagawa A (1994) The cerebral thermo-pooling and hypothermia treatment of critical head injury patients. In: Nagai H (ed) Intracranial pressure IX. Springer, Tokyo, pp 589–599Google Scholar
  7. 7.
    Hayashi N, Hirayama T, Utagawa T, Ohata M (1994) Systemic management of cerebral edema based on a new concept in severe head injury patients. Acta Neurochir [Suppl] 60:541–543Google Scholar
  8. 8.
    Hayashi N, Utagawa A, Kinosita K, Izumi T (1999) Application of a novel technique for clinical evaluation of nitric oxide-induced free radical reactions in ICU patients. Cellular and Molecular Neurobiology 19:3–17PubMedCrossRefGoogle Scholar
  9. 9.
    Kagawa M, Nagao S, Bemana I (1996) Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study. J Neurotrauma 13:273–279PubMedCrossRefGoogle Scholar
  10. 10.
    Kow LM, Pfaff DW (1986) Vasopressin excites ventromedial hypothalamus glucose-responsive neurons in vitro. Physiol Behav 37:153–158PubMedCrossRefGoogle Scholar
  11. 11.
    Lin TW, Kuo YS (1996) Acute pulmonary oedema following administration of vasopressin for control of massive GI tract haemorrhage in a major burn patient. Burns 22:73–75PubMedCrossRefGoogle Scholar
  12. 12.
    Pasko SA, Volosheniuk TG (1990) Disordered phosphorus metabolism and its correction in the acute period of severe craniocerebral trauma. Zh Vopr Neirokhir Im NN Burdenko 3:14–16Google Scholar
  13. 13.
    Stanley BG (1993) Neuropeptide Y in multiple hypothalamic sites controls eating behavior, endocrine, and autonomic system for body energy balance. In: Colmers WF, Wahlestedt C (eds) Biology of neuropeptide Y and related peptide. Humana Press, Totowa, NJ, p 457–509CrossRefGoogle Scholar
  14. 14.
    Temple DL, Leibowitz SF (1994) The neuropeptide Y system (hypothalamus) has a dense concentration of glucocorticoide (type II) receptors that mediate carbon hydrate intake. J Neuroendocrinol 6:479–501CrossRefGoogle Scholar
  15. 15.
    Swan HJC, Ganz W (1983) Hemodynamic measurements in clinical practice: a decade in review. J Am Coll Cardiol 1:103–113PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2004

Authors and Affiliations

  • Nariyuki Hayashi
    • 1
    • 2
  • Dalton W. Dietrich
    • 3
    • 4
  1. 1.Nihon University Emergency Medical CenterTokyoJapan
  2. 2.Department of Emergency and Critical Care MedicineNihon University School of MedicineTokyoJapan
  3. 3.Department of Neurological Surgery, Neurology and Cell Biology and AnatomyUniversity of Miami School of MedicineMiamiUSA
  4. 4.The Miami Project to Cure ParalysisMiamiUSA

Personalised recommendations